Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Researchers will assess how well specific chemotherapy drugs work as an adjunct therapy for dogs recovering from bone cancer surgery.
Researchers will investigate a new treatment for feline oral cancers, using small molecular inhibitors.
Researchers will develop advanced DNA-based techniques for characterizing feline soft-tissue sarcomas, which may help veterinarians provide a more comprehensive diagnosis and improve their ability to choose the most appropriate clinical management strategies for these cancers.
Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.
Researchers will investigate targeted therapies for the treatment of B-cell lymphoma in dogs.
